1998
DOI: 10.1016/s0378-8741(98)00080-4
|View full text |Cite
|
Sign up to set email alerts
|

Subchronic toxicity study in mice fed Spirulina maxima

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
47
0
2

Year Published

2003
2003
2017
2017

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 92 publications
(55 citation statements)
references
References 15 publications
3
47
0
2
Order By: Relevance
“…Mice fed a diet based on Spirulina had no subchronic toxicities after 13 wk of continuous feeding (24). Our diet formulation was similar to published protocols (21,23).…”
Section: Resultsmentioning
confidence: 91%
“…Mice fed a diet based on Spirulina had no subchronic toxicities after 13 wk of continuous feeding (24). Our diet formulation was similar to published protocols (21,23).…”
Section: Resultsmentioning
confidence: 91%
“…Most data is from animal and in vitro experiments and these are discussed in the following section. Extensive toxicological studies in an animal model showed no adverse effects after subchronic treatment [43]. Spirulina has been determined by US FDA as GRAS and this affirmed its use as an ingredient in foods.…”
Section: Safety Of Using Algal Productsmentioning
confidence: 93%
“…Spirulina contains carotenoid pigments, especially betacarotene and zeaxantine, besides phycocoanine (Estrada et al, 2006) and phenolic compounds (Colla et al, 2006), substances with well-known antioxidant activity. The absence of phycotoxins is an advantage of Spirulina when compared to other cyanobacteria and studies on chronic and subchronic toxicity did not reveal any toxic effect related to its intake (Sanchez et al, 2003;Salazar et al, 1998), as long as there was absence of toxigenic cyanobacteria in its culture (Costa et al, 2006). Experiments conducted in different animal models demonstrated that a supplementary diet with Spirulina could promote a decrease in plasma (Iwata et al, 1990;Hosoyamada et al, 1991) and hepatic (De Rivera et al, 1993) total cholesterol, LDL, triglycerides, and phospholipids, besides increasing HDL (high-density lipoprotein) (Hosoyamada et al, 1991).…”
Section: Introductionmentioning
confidence: 99%